Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Employee Health Steps Up as Hurricanes Hit Hospitals

    Employee health professionals hunkered down with their hospital colleagues recently as hurricanes Harvey and Irma hit the contiguous United States and Hurricane Maria subsequently devastated Puerto Rico. While relief efforts were still underway in Puerto Rico as this issue went to press, Hospital Employee Health talked to employee health professionals who were on hospital duty in the path of Harvey and Irma.

  • The Pediatric Airway and Rapid Sequence Intubation in Trauma

    This article will discuss in detail the approach to the pediatric trauma patient, with a strict focus on the pediatric airway.

  • A Link Between Demodex Mites and Rosacea

    The role of Demodex in rosacea appears to be well demonstrated. Since eradication of Demodex is insufficient to resolve rosacea, other pathophysiologic pathways also must be involved.

  • More Good News for GLP-1 RA in Type 2 Diabetes

    Since 2008, the FDA has required all new diabetes medications to provide evidence of cardiovascular (CV) safety. The good news is that several classes of agents have demonstrated not only CV safety, but even efficacy in reducing CV events and (in some cases) all-cause mortality.

  • Menopausal Hormone Replacement

    For women who use or have used hormone replacement for menopausal symptoms, new data should be reassuring that their symptom relief does not come at a cost of increased total or cancer-related mortality.

  • Is It Safe to Use PPIs Long Term?

    Proton pump inhibitors (PPIs) are among the most widely used medications in the United States, thanks to a generally favorable combination of efficacy, tolerability, and safety. Because such a large portion of the adult population uses PPIs, even if a small fraction experiences an adverse effect, it becomes a potentially important issue.

  • The Long-term Picture After Bariatric Surgery

    While often viewed as a last-resort treatment of obesity, bariatric surgery actually is the only intervention demonstrated to improve obesity-related mortality. Strict criteria for payment by insurers and costs that are inaccessible to most of the uninsured have restricted the population who could benefit from bariatric surgery.

  • Opioid-induced Nausea and Vomiting

    Opioids are highly effective when administered for appropriate indications. Unfortunately, opioid-induced nausea and/or vomiting (OINV) can limit opioid effectiveness. In the immediate postoperative period, OINV can stress wound integrity and prolong hospital stay. In the outpatient setting, some patients are faced with the dilemma of accepting lesser levels of pain control in exchange for less OINV as they consider whether they should decrease their opioid dosing schedule.

  • FDA Actions

    In this section: The FDA unveils new adverse events dashboard tool, announces intent to hasten generic drug approvals, greenlights a generic drug to treat multiple sclerosis, greenlights biosimilar to treat multiple types of cancers, gives go ahead to leukemia treatment, and approves updated herpes zoster vaccine.

  • Possible Adverse Cardiovascular Events Slow Osteoporosis Drug Approval Process

    Romosozumab appears to outperform alendronate for fracture prevention in women with osteoporosis, but an increase in cardiovascular adverse events has derailed FDA approval.